Reduced amyloid deposition and improved Aβ clearance have been observed in an AD mouse model after overexpressing ABCA1 transporter [132,133], whereas deletion of the ABCA1 gene decreases levels of apoE protein [134,135] and increases the deposition of Aβ [88,135,136,137]. Here, APOE is linked to Alzheimer disease.